Loufrani, Laurent <br/><br/>
Vasodilator treatment with hydralazine increases blood flow in mdx mice resistance arteries without vascular wall remodelling or endothelium function improvement.  [electronic resource] 

 -  Journal of hypertension  Oct 2005 
 - 1855-60 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0263-6352 
<br/><br/><label>Standard No.: </label>10.1097/01.hjh.0000183944.25832.81  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcholine--pharmacology<br/>Animals<br/>Blood Flow Velocity--drug effects<br/>Blood Pressure<br/>Body Weight<br/>Calcium--pharmacology<br/>Dystrophin--genetics<br/>Endothelium, Vascular--physiology<br/>Enzyme Inhibitors--pharmacology<br/>Hydralazine--administration & dosage<br/>In Vitro Techniques<br/>Male<br/>Mesenteric Arteries--drug effects<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Inbred mdx<br/>Mutation<br/>NG-Nitroarginine Methyl Ester--pharmacology<br/>Nitric Oxide Synthase--antagonists & inhibitors<br/>Nitroprusside--pharmacology<br/>Phenylephrine--pharmacology<br/>Serotonin--pharmacology<br/>Stress, Mechanical<br/>Vascular Resistance<br/>Vasoconstriction--drug effects<br/>Vasoconstrictor Agents--pharmacology<br/>Vasodilation--drug effects<br/>Vasodilator Agents--administration & dosage